Assessment
Questionnaire

Have a symptom?
See what questions
a doctor would ask.
 
Articles » Cryptococcosis: DBMD
 

Cryptococcosis: DBMD

Article title: Cryptococcosis: DBMD

Conditions: Cryptococcosis

Source: DBMD



Cryptococcosis

   
Clinical Features Initial pulmonary infection is usually asymptomatic. Most patients present with disseminated infection, especially meningoencephalitis. In the United States, 85% of cases occur in HIV-infected persons.
Etiologic Agent Cryptococcus neoformans.
Reservoir C. neoformans var. neoformans has been isolated from the soil worldwide, usually in association with bird droppings. Less common etiologic agent, C. neoformans var. gattii has been isolated from eucalyptus trees in tropical and sub-tropical regions.
Incidence 0.2-0.9 cases per 100,000 in the general population. Among persons with AIDS, the annual incidence is 2-4 cases per 1,000.
Sequelae Meningitis may lead to permanent neurologic damage. Mortality rate is about 12%.
Transmission Inhalation of airborne yeast cells and/or basidiospores.
Risk Groups Immunocompromised persons, especially those with HIV infection.
Surveillance Active, population-based surveillance in selected U.S. sites. No national surveillance exists.
Challenges Developing a cost-effective prevention strategy (although fluconazole is effective chemoprophylaxis for persons with AIDS, it does not affect survival and is not considered cost-effective).

December 2001

 
 
 

homepage | back to top
 

By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise